← All stories
● Covered by 1 source · 1 reportMedium impact

Radical Numerics Raises $50M for AI in Biological Intelligence

New to BrevFeed? We gather this story from every outlet covering it into one summary — ranked by real-world impact, not just the latest headline — so you never miss what matters. What is BrevFeed? →

Key points

  • Radical Numerics raised $50M in a seed round led by Emergence Capital.
  • The startup plans to develop multimodal AI models for biological data.
  • Their mission includes drug discovery and biodefense applications.

Overview of Funding

Radical Numerics secured a $50 million seed funding round, supported by Emergence Capital and others.

Notable early investor includes Stripe co-founder Patrick Collison.

Focus on AI and Biology

The company aims to develop AI models that can reason across biological data such as DNA and RNA.

Their goal is to accelerate advancements in drug discovery and cancer diagnostics.

Introduction of Omnii

Along with the funding announcement, Radical Numerics previewed Omnii—their next-gen genome language model.

This model represents their ambition to achieve 'general biological intelligence' in biological systems.

Industry Implications

The investment trend highlights a growing interest in frontier AI applications in healthcare and biosecurity.

As AI advances, the potential for both positive and negative impacts on biology raises ethical considerations.

✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →

The daily brief

One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.

One email a day. Unsubscribe in one click, any time.

Today's brief

Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.

~34 min · 27 stories · Oct 02

▶ Play today's brief Listen on Spotify

New every morning, and the back catalogue is archived by date.

Reporting from

San Francisco startup Radical Numerics raised $50 million for developing AI models focused on biology, aiming to create 'general biological intelligence'. This investment reflects the increasing interest in using AI for drug discovery and detecting biological threats.